AKUMS: CDMO-led growth lifted Q2 revenue 31.9% and EBITDA 106% YoY

What happened

Akums reported Q2 FY27 revenue growth of 31.9% year over year and EBITDA growth of 106%. The article says CDMO volume growth above 20% led the increase, and notes plans to expand Baddi capacity and pursue international contracts.

Confirmed

Global impact / market context

If CDMO demand continues, higher production volumes could support revenue growth and make planned Baddi capacity more useful. International contracts could add sales, but API losses and changing input costs may limit profit growth or require more cash to fund operations.

Analyst inference

The reported quarter combines faster sales growth with a larger increase in EBITDA, a measure of operating earnings before interest, taxes, depreciation and amortization. However, the article gives no absolute financial figures, and API losses and input-cost volatility complicate judging how durable the improvement is.

Analyst inference

What to watch

1. Check whether CDMO volumes continue growing above 20% in later quarters; sustained growth would indicate that the reported revenue increase is not limited to this period. Analyst inference
2. Look for details on Baddi capacity expansion, including timing and spending, since new production space can raise costs before it contributes additional sales. Analyst inference
3. Watch for signed international contracts and updates on API losses and input costs, which could show whether expansion translates into stronger earnings and cash available. Analyst inference

Evidence

• Original source link unavailable